Hosted on MSN11mon
Novo Nordisk's unique structure gives it an extra edge — and riskThe blockbuster success of GLP-1 drugs has put Novo Nordisk — and the 100-year-old company's unique structure — in the spotlight. On Monday, the pharmaceutical giant was named Yahoo Finance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback